The
emergence of peroxidase (POD)-like nanozyme-derived catalytic
therapy has provided a promising choice for reactive oxygen species
(ROS)-mediated broad-spectrum antibacterials to replace antibiotics,
but it still suffers from limitations of low therapeutic efficiency
and unusual addition of unstable H2O2. Considering
that the higher blood glucose in diabetic wounds provides much more
numerous nutrients for bacterial growth, a cascade nanoenzymatic active
material was developed by coating glucose oxidase (GOx) onto POD-like
Fe2(MoO4)3 [Fe2(MoO4)3@GOx]. GOx could consume the nutrient of glucose
to produce gluconic acid (weakly acidic) and H2O2, which could be subsequently converted into highly oxidative •OH via the catalysis of POD-like Fe2(MoO4)3. Accordingly, the synergistic effect of starvation
and ROS-mediated therapy showed significantly efficient antibacterial
effect while avoiding the external addition of H2O2 that affects the stability and efficacy of the therapy system.
Compared with the bactericidal rates of 46.2–59.404% of GOx
or Fe2(MoO4)3 alone on extended-spectrum
β-lactamases producing Escherichia coli and methicillin-resistant Staphylococcus aureus, those of the Fe2(MoO4)3@GOx group
are 98.396 and 98.776%, respectively. Animal experiments showed that
the as-synthesized Fe2(MoO4)3@GOx
could much efficiently promote the recovery of infected wounds in
type 2 diabetic mice while showing low cytotoxicity in vivo.